Myocardial contrast echocardiography (MCE) is a relatively new technique that utilises the intravascular injection of microbubbles of air.' As these bubbles traverse the coronary microcirculation, they produce myocardial opacification that can be seen and measured. During their transit through the myocardium these bubbles remain entirely within the intravascular space and, if they are small, they act as tracers of red blood cell flow.23 Thus MCE can be used to assess the coronary microcirculation in the beating heart. MCE, which can define vessels with a diameter <10 pm, showed that collateral perfusion, which protects the myocardium during acute infarction,78 was more abundant in patients with coronary artery disease than had formerly been believed.7 Regional function is improved when blood flow is provided to infarcted myocardium with abundant collateral perfusion.8 Figure 1 shows short axis views of the heart from a patient with a recent anteroseptal infarction and an occluded left anterior descending artery who had akinesia of the anteroseptal wall and the apex. Injection of microbubbles into the right coronary artery resulted in opacification not only of the right coronary bed but also the medial half of the left anterior descending artery bed (arrows in fig 1A) . When the microbubbles were injected into the left main artery, there was opacification in the lateral part of the bed of the occluded left anterior descending artery (arrows in fig 1B) 
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Current applications of MCE Until recently the clinical applications of MCE were limited to the cardiac catheterisation laboratory and the operating room, because microbubbles capable of producing myocardial opacification from a venous injection were not available. In both the catheterisation laboratory and in the operating room the intra-arterial injections of microbubbles of air have been found to be safe. 45 In the experimental setting and in the cardiac catheterisation laboratory7 8 MCE showed the presence and functional significance of collateral perfusion during myocardial infarction. MCE is superior to coronary angiography, which can define only vessels >100,um in diameter: most myocardial collaterals are considerably smaller. 9 MCE, which can define vessels with a diameter <10 pm, showed that collateral perfusion, which protects the myocardium during acute infarction,78 was more abundant in patients with coronary artery disease than had formerly been believed.7 Regional function is improved when blood flow is provided to infarcted myocardium with abundant collateral perfusion.8 Figure 1 shows short axis views of the heart from a patient with a recent anteroseptal infarction and an occluded left anterior descending artery who had akinesia of the anteroseptal wall and the apex. Injection of microbubbles into the right coronary artery resulted in opacification not only of the right coronary bed but also the medial half of the left anterior descending artery bed (arrows in fig 1A) . When the microbubbles were injected into the left main artery, there was opacification in the lateral part of the bed of the occluded left anterior descending artery (arrows in fig 1B) Potential clinical applications ofMCE using venous injection ofcontrast Figure 3 shows images from a patient with a severely stenotic dominant right coronary artery who at baseline showed no myocardial opacification in the posterior half of the heart when microbubbles were injected into the cross-clamped aorta during cardioplegia delivery. After that vessel was bypassed and microbubbles were reinjected into the aorta, perfusion of the posterior half of the heart was improved. MCE can also be used to define the spatial distribution of myocardial perfusion during retrograde infusion of cardioplegia. ' Figure 6 shows images from four stages in a dog after left atrial injection of contrast. 20 During baseline (A) and pharmacologically induced hyperaemia (B) and in the absence of any coronary stenosis flow to the two beds was identical. When, during hyperaemia, a stenosis was placed on either the left anterior descending (C) or the left circumflex (D) artery, relative hypoperfusion (denoted by arrows) was noted in regions supplied by these vessels. These areas of hypoperfusion corresponded well with actual flow abnormalities measured using radiolabelled microspheres and the ratios of intensities from the two beds also correlated closely with the ratios of perfusion to the two beds.20 Thus both the spatial extent and amount of myocardium susceptible to ischaemia can be defined by MCE, which can form the basis for risk stratification and management of patients with coronary artery disease.
As well as the topography of abnormal perfusion (figs 1 to 6) more complex aspects of myocardial perfusion such as myocardial blood flow and volume (volume of blood within the myocardial microvasculature) can also be measured by MCE.21-24 Although blood flow and volume are usually closely coupled, they may not be, as when a coronary vasodilator, such as dipyridamole or adenosine, is used to measure coronary flow reserve. Coronary flow reserve is then expressed as the ratio of hyperaemic basal blood flow.
Coronary flow reserve depends on the ability of the coronary microvasculature to dilate. Because there is no method of directly assessing the coronary microvasculature, measurement of coronary blood flow has been used to assess coronary microvascular reserve. The problem with measuring coronary blood flow as an indicator of coronary reserve is that potent coronary vasodilators abolish autoregulation, and under these circumstances coronary blood flow is determined by the coronary driving pressure. Thus any change in aortic pressure will lead to either an over or under estimation of the coronary reserve. Direct estimation of pharmacologically induced changes in myocardial blood volume by MCE, however, gives a more appropriate assessment of microvascu-. lar reserve. 23 
